191864-24-1

• 常用中文名：ethyl 3-[2-(dimethylamino)ethyl]-5-[[(4S)-2-oxo-1,3-oxazolidin-4-yl]methyl]-1H-indole-2-carboxylate
• 常用英文名：ethyl 3-[2-(dimethylamino)ethyl]-5-[[(4S)-2-oxo-1,3-oxazolidin-4-yl]methyl]-1H-indole-2-carboxylate
• CAS号：191864-24-1
• 分子式：C₁₉H₂₅N₃O₄
• 分子量：359.42000
• 发布时间：2016-11-16 22:39:24
• 更新时间：2024-01-09 19:06:27

名称

• 英文名: ethyl 3-[2-(dimethylamino)ethyl]-5-[[(4S)-2-oxo-1,3-oxazolidin-4-yl]methyl]-1H-indole-2-carboxylate
• 英文别名: ethyl 3-(2-dimethylaminoethyl)-5-[(4S)-2-oxooxazolidin-4-ylmethyl]-1H-indole-2-carboxylate; Zolmitriptan related compound D; (S)-ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxo-1,3-oxazolidin-4-yl)methyl]-1H-indole-2-carboxylate; 1H-Indole-2-carboxylic acid,3-(2-(dimethylamino)ethyl)-5-(((4S)-2-oxo-4-oxazolidinyl)methyl)-,ethyl ester; Zolmitriptan 2-carboxylic acid ethyl ester; ethyl 3-(2-dimethylaminoethyl)-5-[(4S)-2-oxo-1,3-oxazolan-4yl-methyl]-1H-2-indole carboxylate; (S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate; Zolmitriptan related compound D RS [USP]; (S)-3-(2-dimethylaminoethyl)-5-[2-oxo-1,3-oxazolidin-4-ylmethyl]-1H-indol-2-carboxylic acid ethyl ester

物化性质

• 分子式: C₁₉H₂₅N₃O₄
• 分子量: 359.42000
• 精确质量: 359.18500
• PSA: 87.15000
• LogP: 1.73960

安全

• 危险品运输编码: NONH for all modes of transport

合成路线

659738-68-8 124-40-3 ~89% 191864-24-1

文献：LABORATORIOS VITA, S. A. Patent: WO2004/14901 A1, 2004 ; Location in patent: Page 16-17 ;

63-91-2 ~% 191864-24-1

文献：Moloney, Gerard P.; Robertson, Alan D.; Martin, Graeme R.; MacLennan, Steven; Mathews, Neil; Dodsworth, Susan; Sang, Pang Yih; Knight, Cameron; Glen, Robert Journal of Medicinal Chemistry, 1997 , vol. 40, # 15 p. 2347 - 2362

949-99-5 ~% 191864-24-1

文献：Moloney, Gerard P.; Robertson, Alan D.; Martin, Graeme R.; MacLennan, Steven; Mathews, Neil; Dodsworth, Susan; Sang, Pang Yih; Knight, Cameron; Glen, Robert Journal of Medicinal Chemistry, 1997 , vol. 40, # 15 p. 2347 - 2362

89288-22-2 ~% 191864-24-1

文献：Moloney, Gerard P.; Robertson, Alan D.; Martin, Graeme R.; MacLennan, Steven; Mathews, Neil; Dodsworth, Susan; Sang, Pang Yih; Knight, Cameron; Glen, Robert Journal of Medicinal Chemistry, 1997 , vol. 40, # 15 p. 2347 - 2362

17193-40-7 ~% 191864-24-1

文献：Moloney, Gerard P.; Robertson, Alan D.; Martin, Graeme R.; MacLennan, Steven; Mathews, Neil; Dodsworth, Susan; Sang, Pang Yih; Knight, Cameron; Glen, Robert Journal of Medicinal Chemistry, 1997 , vol. 40, # 15 p. 2347 - 2362

139264-55-4 ~% 191864-24-1

文献：Moloney, Gerard P.; Robertson, Alan D.; Martin, Graeme R.; MacLennan, Steven; Mathews, Neil; Dodsworth, Susan; Sang, Pang Yih; Knight, Cameron; Glen, Robert Journal of Medicinal Chemistry, 1997 , vol. 40, # 15 p. 2347 - 2362

69472-61-3 ~% 191864-24-1

文献：Moloney, Gerard P.; Robertson, Alan D.; Martin, Graeme R.; MacLennan, Steven; Mathews, Neil; Dodsworth, Susan; Sang, Pang Yih; Knight, Cameron; Glen, Robert Journal of Medicinal Chemistry, 1997 , vol. 40, # 15 p. 2347 - 2362

5407-04-5 ~% 191864-24-1

文献：Moloney, Gerard P.; Robertson, Alan D.; Martin, Graeme R.; MacLennan, Steven; Mathews, Neil; Dodsworth, Susan; Sang, Pang Yih; Knight, Cameron; Glen, Robert Journal of Medicinal Chemistry, 1997 , vol. 40, # 15 p. 2347 - 2362

152305-23-2 ~% 191864-24-1

文献：Moloney, Gerard P.; Robertson, Alan D.; Martin, Graeme R.; MacLennan, Steven; Mathews, Neil; Dodsworth, Susan; Sang, Pang Yih; Knight, Cameron; Glen, Robert Journal of Medicinal Chemistry, 1997 , vol. 40, # 15 p. 2347 - 2362